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Abstract  
Despite existing knowledge about the role of the A Disintegrin and Metalloproteinase 10 
(ADAM10) as the -secretase involved in the non-amyloidogenic processing of the amyloid 
precursor protein (APP) and Notch signalling we have only limited information about its 
regulation. In this study, we have identified ADAM10 interactors using a split ubiquitin 
yeast two hybrid approach. Tetraspanin 3 (Tspan3), which is highly expressed in the murine 
brain and elevated in brains of Alzheimer´s disease (AD) patients, was identified and 
confirmed to bind ADAM10 by co-immunoprecipitation experiments in mammalian cells in 
complex with APP and the -secretase protease presenilin. Tspan3 expression increased the 
cell surface levels of its interacting partners and was mainly localized in early and late 
endosomes. In contrast to the previously described ADAM10-binding tetraspanins, Tspan3 
did not affect the endoplasmic reticulum to plasma membrane transport of ADAM10. 
Heterologous Tspan3 expression significantly increased the appearance of carboxy-terminal 
cleavage products of ADAM10 and APP, whereas N-cadherin ectodomain shedding 
appeared unaffected. Inhibiting the endocytosis of Tspan3 by mutating a critical cytoplasmic 
tyrosine-based internalization motif led to increased surface expression of APP and 
ADAM10. After its downregulation in neuroblastoma cells and in brains of Tspan3-
deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a 
compensatory increase in the expression of Tspans 5 and 7, respectively. In conclusion, our 
data suggest that Tspan3 acts in concert with other tetraspanins as a stabilizing factor of 
active ADAM10, APP and the -secretase complex at the plasma membrane and within the 
endocytic pathway.  
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Introduction 
 
Tetraspanins were discovered in the early 90s as proteins which span the membrane four times. 
Today, the 33 known mammalian members of the tetraspanin family are involved in diverse 
biological processes including the regulation of immune responses, infection with pathogens and 
cancer progression [1]. As glycosylated and palmitoylated proteins, tetraspanins interact with each 
other and with many transmembrane proteins including integrins, cell adhesion proteins, growth 
factor and cytokine receptors and membrane embedded enzymes [2-5]. Such an interaction network 
of tetraspanins and transmembrane proteins was previously referred to as the “tetraspanin web” [2]. 
The transmembrane domains and the large extracellular loop of tetraspanins as well as the 
surrounding lipid composition contribute to these protein interactions. Most likely, different 
tetraspanins act in concert in a tissue-specific context in the regulation of the stability and 
intracellular trafficking of membrane proteins. This affects the steady state level and localization of  
tetraspanin partner proteins in a given cellular or membrane compartment [1].  
Members of the ADAM (A Disintegrin And Metalloproteinase) family which can mediate the 
proteolytic processing of membrane proteins referred to as ectodomain shedding [6] were also 
found to interact with certain tetraspanins. In particular, the interaction of tetraspanins with 
ADAM10 has raised attention due to its proteolytic function as an amyloid precursor protein (APP) 
-secretase, as the sheddase of the cellular prion protein (PrPc) and as a Notch1 receptor site 2 
proteinase [7-10] was found to interact with members of the tetraspanin superfamily. A subfamily 
of tetraspanins, TspanC8, with eight cysteines in the large extracellular domain, appeared to have 
high affinity to ADAM10. Tspan5, 10, 14, 15, 17 and 33 interact with ADAM10 and regulate its 
exit from the ER and transport to the plasma membrane where ectodomain shedding occurs [11-14]. 
Overexpression or RNAi-mediated downregulation of the TspanC8s caused changes in the 
maturation process and stabilized the surface expression of ADAM10 [12]. The interaction between 
different TspanC8 proteins and ADAM10 starts in the ER [12] and mainly involves the large 
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extracellular loop at the side of the TspanC8s and the membrane-proximal domain as well as the 
disintegrin domain in the ADAM10 protein [15]. The interaction of ADAM10 with different 
TspanC8s may differentially affect the shedding of ADAM10 substrates including Notch1 [16]. It is 
of note that the TspanC8 family was also recently implicated in a possible functional clustering of 
the -secretase complex and the APP -secretase, ADAM10 [17].  
Tetraspanin-3 (Tspan3) is another member of the tetraspanin superfamily but only contains six 
cysteines in the large luminal domain. It was shown to associate with claudin-11 and beta1 integrin 
thereby regulating the proliferation and migration of oligodendrocytes [18,19]. Tspan3 is expressed 
in all stages in oligodendrocyte development but is most prominently expressed in neurons and 
astrocytes [19]. In brain, Tspan3 associates with the Nogo-A receptor sphingosine-1-phosphate 
receptor 2 (S1PR2). Tspan3 knockdown reduced the Nogo-A-induced S1PR2 clustering, cell 
spreading and the inhibition of neurite outgrowth [20]. In Xenopus leavis embryos Tspan3 is 
expressed in migratory neural crest cells [21]. Tspan3 was also found to be a causative factor in the 
development of acute myelogenous leukemia (AML) and deficiency of Tspan3 led to an impaired 
stem cell-renewal and disease propagation [22]. 
Using a yeast split-ubiquitin based screening system we identified Tspan3 as a binding partner of 
ADAM10. This interaction did not affect the trafficking or maturation of the protease or its ability 
to cleave the neuronal cadherin (N-cadherin). However, cell-based experiments revealed that 
Tspan3 affected the stabilization of ADAM10 and APP at the cell surface. Our experiments suggest 
that Tspan3 is part of an interaction scaffold that associates with APP and - and -secretases at the 
plasma membrane and within the endocytic pathway. 
 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
   5 
 
Material and Methods 
Antibodies 
The following antibodies were used: anti-ADAM10 antibody EPR5622 (IB, Abcam, Cambridge, 
UK previously GenTex, Irvine, USA), anti-ADAM10 antibody raised against a the C-terminus of 
ADAM10 (IP, [12]), MAB946 anti-ADAM10 ectodomain (FACS, R&D Systems, Minneapolis, 
USA), anti-ADAM17 antibody A300D [23], anti-actin (IB, Sigma-Aldrich, Munich, Gemany), 
B63.2 anti-APP C-terminus (IB, a kind gift of Wim Annaert, Leuven, Belgium), anti-EEA1 (IF, 
Cell Signaling Technology, Danvers, USA), FL-335 anti-GAPDH (Santa Cruz Biotechnology, 
Dallas, USA), 9B11 anti-myc (IB and IF, Cell Signaling Technology, Danvers, USA), anti-myc (IP, 
GTX30518, GenetTex, Irvine, USA), anti-N-Cadherin (BD Transduction Laboratories, Heidelberg, 
Germany), anti-PDI (A6) (Abcam, Cambridge, UK), MAB 5232 anti-Presenilin-1 C-terminal loop 
(IB, Merck Millipore, Darmstadt, Germany), AB1563 anti-Presenilin-1 N-terminal (IB, Merck 
Millipore, Darmstadt, Germany), L2T2 anti-LIMP-2 (IF, IB [24]), anti-PDI (IF, Santa Cruz 
Biotechnology, Heidelberg, Germany), POM1 anti-PrP
c
 (IB, Prof. Dr. A. Aguzzi, Zürich, 
Switzerland), anti-Rab5 (IF, Synaptic Systems, Göttingen, Germany), H4B4 anti-LAMP2 (IF, 
DSHB, Iowa Ciy, USA), anti-E7 beta-Tubulin (DSHB Iowa Ciy, USA), anti-Tspan3 (IB, IP, IF, 
IHC, antibody produced by Pineda, Berlin, Germany against a synthetic peptide corresponding to 
the last 19 amino acids of the C-terminus of mouse Tspan3).  
 
Split-Ubiquitin Membrane Yeast Two Hybrid Screening 
The split-ubiquitin yeast two hybrid screen was performed as already described [Prox et al, 2012]. 
Briefly, cDNA of murine ADAM10 was cloned into a yeast expression vector (pTMBV4) and C-
terminally fused to a Cub-LexA-VP16 cassette. Expression of the ADAM10 bait construct was 
monitored using positive (NubI) and negative (NubG) controls as supplied by the manufacturer. 
ADAM10 bait construct was co-transfected with N-terminally NubG-tagged murine cDNA brain 
library (MoBiTec) into NMY51 yeast and seeded on selective media plates (-Leu, -Trp, -His). After 
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incubation for 3-5 days at 30°C clones were selected and expanded. Prey plasmids were extracted 
and analyzed by sequencing (GATC).  
 
Cell culture, transfection and plasmids 
All cells were cultured in DMEM (Thermo Fisher Scientific, Waltham, USA) with 10% fetal calf 
serum (FCS) and 1% penicillin/streptomycin at 37°C, 5% CO2 atmosphere and 95% relative 
humidity. HEK293 and N2A cells stably overexpressing APP695 or APP695swe (Swedish mutant 
provided by Michael Willem, DZNE, Munich) were additionally supplemented with 200 µg/ml of 
the antibiotic G418. HEK293 cells deficient for ADAM10 (A10-/-) or ADAM17 (A17-/-)were 
generated by using the CRISPR/Cas9 system. The cells were transiently transfected with 
Polyethylenimin Max (PEI, Polysciences, Hirschberg, Germany). For inhibition of ADAM10 cell 
culture medium was supplemented with 10 µ  of the hydroxamate-based inhibitor GI254023X 
(Iris Biotech, Marktredwitz, Germany) for 12 h. Mammalian expression vectors were pCI-neo 
(human APP695), pcDNA3.1Hygro (ADAM10) and pFrog3 (murine Tspan3-myc and Tspan15-
myc) derived from pcDNA3 (Thermo Fisher Scientific, Waltham, USA) [25]. The myc-epitope was 
inserted after the last amino acid of Tspan3 or Tspan15, respectively. The myc-tagged murine 
Tspan7 expression plasmid was purchased from OriGene Technologies Rockville, USA 
(MR221859). 
 
Generation of the Tspan3Y243L mutant 
Tspan3Y243L was generated by mutating the cDNA sequence of myc-tagged wild type Tspan3. 
cDNA sequence coding for the amino acid Tyrosine (Y) at position 243 was exchanged by the 
sequence coding for Leucine (L). Myc-tagged Tspan3Y243L was again subcloned into the pFrog3 
vector. The following primers were used:  
5‘-CAGTGATGAGGAGCTCAGCGGCAGGATCTCTACTCC-3’; 5’-GGAGTAGAGATCCTGC
CGCTGAGCTCCTCATCACTG-3’ 
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Protein extraction from cells and organs 
Cells were washed three times with cold PBS, scraped off in 1 mL PBS plus 0.04% proteinase 
inhibitor cocktail (Complete
TM
, Roche, Diagnostics, Mannheim, Germany) and centrifuged for 
20 min at 4000 g. The cell pellet was resuspended in lysis buffer (1 mM EGTA, 5 mM Tris, 
250 mM Saccharose, pH 7,4) containing 1% Triton X-100 and 0.04% proteinase inhibitor cocktail. 
Following lysis, cells were sonicated two times for 15 sec at 60 Hz, incubated for 1 h on ice and 
sonicated again. Cell lysates were centrifuged for 10 min at 14,000 g at 4
o
C to remove cellular 
debris and nuclei. 
For protein extraction from organs, tissue was homogenized in RIPA lysis buffer (20 mM Tris-HCl 
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP40, 2.5 mM sodium deoxocholate, 
0.04% proteinase inhibitor cocktail) using the Precellys homogenization system (Bertin Corp., 
Rockville, USA). Thereafter, homogenates were sonicated two times for 15 sec at 60 Hz, incubated 
on ice for 1 h and centrifuged for 10 min at 14,000 g at 4
o
C. Protein concentration was determined 
using the Pierce
TM
 BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, USA). Finally, 
lysates were prepared for SDS-PAGE by incubation with reducing SDS-PAGE loading buffer 
(625 mM Tris base, 10% SDS, 50% glycerol, 250 mM DTT) and boiling for 5 min at 95°C. 
Peptide N-Glycosidase F (PNGase F) digestion 
Mouse brain homogenates were prepared as described above. After homogenization, equal amounts 
of total protein were incubated for 5 min at 95°C with 5x denaturing buffer (250 mM Na2PO4, pH 
8.0, 1% SDS, 4% β-mercaptoethanol). After denaturation 5x Triton solution (7.5% Triton X-100, 
50 mM EDTA) and proteinase inhibitor cocktail were added. The samples were incubated with 
PNGase F (Roche, Diagnostics, Mannheim, Germany) or ddH2O for 2 h at 37°C and prepared for 
SDS-PAGE.  
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SDS-PAGE and immunoblotting  
Equal amounts of extracted proteins were loaded on 10% SDS-PAGE or 4-12% gradient BIS/Tris 
NuPAGE
TM
 gels (Thermo Fisher Scientific, Waltham, USA) and separated for 1.5 . Thereafter, 
proteins were transferred to nitrocellulose membranes (Whatman, GE Healthcare, Little Chalfont, 
UK) by tank blotting for two hours at 0.8 A and 4°C. For the detection of APP C-terminal 
fragments blotting was performed at 0.25 mA for two hours at 4° C. To prevent unspecific antibody 
binding the membranes were incubated with 5% milk solution in TBS plus 0.1% Tween (TBS-T). 
The membranes were incubated over night with primary antibodies diluted in 5% milk solution at 
4°C. After three washes in TBS-T, immunoblots were incubated with peroxidase-coupled 
secondary antibodies for 1 h at room temperature. Membranes were washed again and developed 
using the Lumigen ECL Ultra detection solution (Lumigen Inc., Southfield, USA) and the 
chemiluminescence detection system LAS4000 (GE Healthcare, Little Chalfont, UK). Signal 
intensities were quantified with the quantification software ImageJ and statistically analyzed. 
 
Co-Immunoprecipitation experiments 
Cells or brain tissues were lysed with immunoprecipitation buffer (120 mM NaCl, 50 mM Tris-
HCl, 0.04% complete proteinase inhibitor cocktail, pH 7.4) containing 0.5% NP-40 (Sigma-Aldrich, 
Munich, Gemany) as described above. 60 µL of lysates were removed as input controls. Residual 
lysate amounts were incubated with primary antibodies over night at 4°C under continuous rotation. 
50 µL of Protein G coupled Dynabeads (Thermo Fisher Scientific, Waltham, USA) were washed 
with lysis buffer and incubated with SEA-blocking buffer (Thermo Fisher Scientific, Waltham, 1:1 
diluted with lysis buffer) over night at 4°C to reduce unspecific binding of proteins. Next day, 
Dynabeads were added to the lysate-antibody complexes and incubated for 30 min at room 
temperature. Beads were washed three times with lysis buffer and incubated with 50 µL of reducing 
SDS-PAGE loading buffer for 20 min at 65°C to elute precipitated proteins. Input controls and 
immunopreciptates (IP) were then loaded on 10% SDS-PAGE or 4-12% gradient BIS/Tris 
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NuPAGE
TM
 gels (Thermo Fisher Scientific, Waltham, USA) and respective amounts were 
determined by immunoblotting. 
 
Surface Biotinylation 
Biotinylation of surface proteins was performed with the biotinylation reagent EZ-Link
TM
 Sulfo-
NHS-SS-Biotin (Thermo Fisher Scientific, Waltham, USA). All steps were done on ice (4 °C) to 
minimize endocytosis of cell surface proteins. Cells were washed three times with ice-cold PBS-
CM (0.1 mM CaCl2, 1 mM MgCl2 in PBS) and incubated with 3 ml biotin solution (1 mg/ml in 
PBS-CM) (+biotin) or PBS-CM (-biotin) for 30 min. Unreacted Sulfo-NHS-SS-Biotin was removed 
by incubation with quenching buffer (50 mM Tris-HCl/PBS-CM, pH 8.0) for 10 min. Cells were 
washed again three times with PBS-CM, harvested and lysed with biotinylation lysis buffer (50 mM 
Tris, 150 mM NaCl, 1% Triton-X100, 0.04% proteinase inhibitor cocktail) as described above. 
50 µL of the total cell lysates were removed as expression control (total) and prepared for SDS-
PAGE. Equal amounts of residual lysates were incubated with 70 µL of washed Pierce
TM
 
Streptavidin Agarose beads (Thermo Fisher Scientific, Waltham, USA) for 1 hour at 4°C and 
continuous rotation. Afterwards, beads were washed five times with lysis buffer and incubated with 
reducing SDS-PAGE loading buffer for 20 min at 65°C to elute bound proteins. Finally, samples 
were prepared for SDS-PAGE and immunoblotting. 
 
Flow Cytometry 
Cells were washed with cold PBS and incubated with 2 ml Accutase (PAA Laboratories, 
Dartmouth, USA) for 5 min at 37°C to detach cells from cell culture dishes. Cells were counted and 
5x10
5
 cells per sample incubated with anti-ADAM10 antibody (MAB946, 1:100) for 1 h at 4°C. 
Cells were washed with MACS buffer (PBS containing 0.5% BSA and 2 mM EDTA) and incubated 
with an IgG2b goat anti-rat Alexa-488 labeled secondary antibody for 1 h at 4 C. Cells only 
incubated with secondary antibody were used as negative control. After another washing step cells 
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were analyzed by flow cytometry using the BD FACS Canto
TM 
II system (BD Biosciences, 
Heidelberg, Germany).  
 
Immunofluorescence analysis 
HeLa cells were grown on coverslips in six-well cell culture dishes. 48 h past transfection cells 
were washed three times with ice-cold PBS and fixed for 20 min with 4% (w/v) paraformaldehyde 
in PBS. Cells were permeabilized with 0.2% saponin in PBS, followed by 10 min incubation with 
0.2% saponin, 0.12% glycine in PBS. Afterwards cells were incubated for 1 h with blocking 
solution (10% (v/v) FCS, 0.2% saponin, PBS). Blocking solution was also used as diluent for 
primary and secondary antibodies. Coverslips were incubated with 50 µL antibody solution over 
night at 4 °C. After five times of washing with 0.2% saponin in PBS cells were incubated for 1 h 
with Alexa®-488 and -594 labeled secondary antibodies. Again, cells were washed five times with 
washing buffer plus two additional washing steps in ddH2O. Coverslips were mounted with 
DAPCO/mowiol containing 0.1 µg/mL DAPI (4-,6-diamidino-2-phenylindole; Sigma-Aldrich, 
Munich, Gemany) for nucleus staining. Confocal pictures were acquired with an Olympus FV1000 
confocal laser scanning microscope. 
 
siRNA-based knockdown experiments 
Cells were seeded in 6 cm cell culture dish plates. According to the manufacturer’s instructions 
cells were transfected with 5 nM of human Tspan3 (ON-TARGETplus® smart pool #10099 siRNA, 
GE Healthcare Dharmacon, Chicago, USA), murine ADAM10 siRNA (Stealth RNAi
TM
 siRNA 
#1320001, Thermo Fisher Scientific, Waltham, USA) or respective non-targeting control siRNA 
using INTERFERin® (PolyPlus, Illkirch-Graffenstade, France). The Procedure was repeated after 
48 h and cells were harvested additional 24 h later. For the analysis of the effect of Tspan3 
expression on APP processing, cells were additionally transfected with the Tspan3-myc expression 
construct as described above.  
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Quantitative RT-PCR 
RNA was extracted from cells or brain tissue using the NucleoSpin® RNA Kit (Macherey Nagel, 
Düren, Germany). 1 µg of extracted RNA was reverse transcribed with the RevertAid
TM
 First 
Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, USA) using a Random Hexamer 
primer according to the manufacturers protocol. Gene transcription was determined by real-time 
PCR analysis of 0.5 µL cDNA on a LightCycler
®
 480 Real-time PCR System (Roche, Diagnostics, 
Mannheim, Germany) in 10 µL reaction volume in triplicates. Relative gene transcription was 
calculated by using ΔCt values normalized to the transcription level of a housekeeping gene. The 
actual PCR efficiency of each assay was determined by serial dilution of standards and these values 
were used for calculation. T-tests were performed on the mean ΔCt values of the technical triplicate 
measurements.  
 
Generation of Tspan3 mutant mice 
Tspan3 knockout mice were created by transcription activator-like effector nucleases (TALEN) 
mediated genome editing. The TALEN were designed to target exon2 of the Tspan3 gene. The 
following TALEN-repeat domain sequences were used. Left TALEN: NN NG NN NG NI HD NI 
HD NN HD NG HD NG NG HD HD HD NG NN HD, right TALEN: NN NI NI NI NI NN HD NI 
NI NN NN HD NG HD HD NG NI HD NI. The Tspan3-TALEN mRNA was co-injected with a 
single stranded synthetic oligodeoxynucleotide, bearing three stop codons and one XbaI restriction 
site, into zygotes and transferred into mice, ssOligodeoxynucleotide sequence: 
5’-ACGACTATGACCACTTCTTCGAGGATGTGTACACGCTCTAACCTGCCGTGGTGATAG
CATAGTAGTATGAGTCTAGATTTTCATCATTGGCCTGATCGGCTGCTGTGC-3’. TALEN 
RNA precursors were generated and microinjected into male nucleoli of zygotes isolated from 
C57BL/6N mice as described elsewhere [26]. Founder mice were genotyped for TALEN-mediated 
frameshift mutations. Resulting from this, mice with a 26 bp insertion mutation inducing a 
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translational stop codon within exon2 of the Tspan3 gene were used for further breeding and 
analysis. 
Animal experiments 
All animal works were approved by the Animal welfare committee of the Christian Albrechts-
University of Kiel (Germany) and were performed according to the guidelines of the Federation of 
European Laboratory Animal Science Associations (FELASA). 
 
Bioinformatics and Statistical analysis 
Sequence alignment of amino acid sequences of human TspanC8 and TspanC6 tetraspanins was 
performed with the multiple sequence alignment tool Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). Statistical significances were tested with unpaired 
Student’s t-tests or one-way ANOVA followed by Bonferroni’s multiple compariosons test  using 
statistical analysis software GraphPad Prism. Error bars indicate the mean +/- standard deviation 
(SD). Statistical significance was considered as p-values:* p<0.05, ** p<0.01, ***p<0.001  
 
 
 
 
 
Results 
ADAM10-Tspan3 interaction in yeast and mammalian cells 
We have previously identified Tspan15 as an ADAM10 interacting protein using a split-ubiquitin 
yeast screening assay [12] (Fig.1A(I)). Applying the same approach using mouse brain cDNAs 
encoding for N-terminal tagged proteins as prey and mADAM10 as bait, we found Tspan3 as an 
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additional ADAM10 interactor. Since yeast cells expressing both mouse ADAM10 and Tspan3 or 
Tspan15 as a positive control grew on tryptophan/leucine/histidine-deficient media plates we 
concluded a close proximity of bait and prey since only then ubiquitin was reconstituted and the 
histidine 3 gene was transcriptionally activated (Fig. 1A). In contrast to Tspan15 belonging to a 
subfamily of tetraspanins characterized by the presence of eight cysteines (TspanC8) in their large 
extracellular loop Tspan3 is evolutionary and structurally different with only six cysteines 
(TspanC6) in the extracellular domain (Fig. 1B). By analysing the expression of Tspan3 in different 
mouse tissues we found it most abundantly expressed in brain and intestine with hardly any 
expression in lung, liver and bone marrow (Fig. 1C). Deglycosylation experiments revealed that 
Tspan3 is glycosylated and the degree of glycosylation differs between different tissues 
(Fig. 1C,D). Interestingly, by analysing post mortem human cortex samples (overview in Suppl. 
Fig.S1) we found a twofold increased expression of Tspan3 in brains of AD patients compared to 
age-matched control samples (Fig. 1E). Tspan3 expression was predominantly found in murine 
neurons of the frontal cortex, the hippocampus and in Purkinje cells of the cerebellum (Suppl. 
Fig. S2).  
To also validate the interaction of Tspan3 and ADAM10 in mammalian cells we expressed a C-
terminally myc-tagged mouse Tspan3 and wild type mouse ADAM10 in HeLa cells and co-
precipitated both proteins with anti-myc and anti-ADAM10 antibodies, respectively (Fig. 1F). 
Tspan3 could be found in the precipitate after the pulldown of overexpressed and endogenous 
ADAM10 (Fig. 1F(I)). Vice versa, ADAM10 was found in the precipitate after Tspan3 pulldown 
(Fig. 1F(II)). As a positive control we included the co-expression of Tspan15 and ADAM10 
revealing the established association [12] between both proteins (Fig.1F). As negative controls 
immunoprecipitations of cells were included which were transfected with constructs expressing 
ADAM10 alone or the structurally related ADAM17 protease. We only found co-precipitation of 
Tspan3 with ADAM10 and not with ADAM17 (Suppl. Fig. S3). To also confirm the interaction 
between ADAM10 and Tspan3 at the endogenous level we used mouse brain homogenates from 
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wild type and Tspan3 knockout mice and precipitated Tspan3 (Fig.1G). We found Tpsan3 in the 
precipitates from wild type brain but not in the knockout precipitate nor in the antibody or bead 
control samples. Importantly, ADAM10 as well as full length APP (fl-APP) and the APP carboxy-
terminal fragment (APP-CTF) was only found in the precipitate from wild type brain. These 
experiments demonstrate that Tspan3 is an endogenous relevant interaction partner of ADAM10 
and APP.  
Our data suggest that Tspan3 is a tetraspanin member preferentially expressed in the central 
nervous system with an apparently higher expression in AD brains. Studies in yeast and mammalian 
cells suggest a specific interaction of Tspan3 with ADAM10 (-secretase) and APP.  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
   15 
 
 
Figure 1: Tspan3 is a new ADAM10 interaction partner. (A) (I) The principle of the Split-
Ubiquitin yeast two Hybrid System is depicted (modified from [27]). ADAM10 is fused to the C-
terminal part of ubiquitin (Cub) and an artificial transcription factor LexA (LexA-VP16) expressed 
in yeast together with N-terminal NubG tagged proteins from a murine brain cDNA library. The 
close proximity between the ADAM10 bait protein and an interaction partner leads to the 
reconstituion of ubiquitin. Cellular ubiquitin proteases release the transcription factor LexA, which 
activates HIS3 gene transcription and allows yeast clones to grow on selective media plates lacking 
histidin (His). (II-III) ADAM10 bait protein was co-expressed with the identified Tspan3 (Tsp3) 
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and Tspan15 (Tsp15) prey proteins and controls in yeast. Expression of bait and prey proteins is 
verified by growth of yeast clones on Leu/Trp-deficient media and the interaction of ADAM10 and 
Tspan3 is monitored on Leu/Trp/His-lacking media plates in comparison to controls (“+” and “-“). 
(B) Tspan3 belongs to the tetraspanins characterized by six cysteines in the large extracellular loop 
and is evolutionary distinct from the group of tetraspanins with eight cysteines (TspanC8 which e.g. 
includes Tspan15). (C) Immunoblot analysis of murine tissues reveals prominent Tspan3 
expression in the central nervous system. Tspan3 is differentially glycosylated in different tissues. 
(D) Tspan3 is a glycosylated protein. PNGase F digestion of murine brain homogenates decreases 
the molecular weight of Tspan3 from 40 kDa in untreated (-) to a molecular weight of 25 kDa in 
PNGase F treated (+) samples. Successful deglycosylation by PNGase F digestion is verified by the 
decrease of the molecular weight of the lysosomal integral membrane protein-2 (LIMP-2), which is 
a highly glycosylated protein. (E) Upregulation of Tspan3 expression in post-mortem prefrontal 
cortex samples (more information in Suppl. Fig. S1) of control and Alzheimer`s disease (AD) 
patients as revealed by immunoblot of the tissue samples and quantification. (F) Mammalian 
expression constructs of murine ADAM10, murine Tspan3-myc and Tspan15-myc were transiently 
co-expressed in HeLa cells. (I) Tspan3-myc (40 kDa) and Tspan15-myc (25 kDa) were precipitated 
(IP) using an anti-myc antibody. Co-precipitation (CoIP) of ADAM10 was detected with an anti-
ADAM10 antibody, pro (p) ADAM10, 95 kDa, mature (m) ADAM10, 75 kDa. (II) ADAM10 was 
precipitated and co-precipitation of Tspan3- and Tspan15-myc was detected. (G) Tspan3 was 
precipitated from murine brain homogenates (wt: wild type; Tspan3 ko: Tspan3 knockout) using a 
C-terminal specific anti-Tspan3 antibody and co-precipitation of mADAM10, fl-APP and APP-CTF 
was observed. Abbreviations: murine ADAM10 (A10), murine Tspan3-myc (Tsp3), murine 
Tspan15-myc (Tsp15), empty vector (V), full length (fl), C-terminal fragment (CTF), antibody 
control (ab ctrl), asterisk marks immunoglobulin signals. 
 
 
Tspan3 does not affect the maturation and surface expression of ADAM10 as compared to 
Tspan15  
To address the question of whether the interaction between ADAM10 and Tspan3 has a similar 
impact on the function of ADAM10 as described for Tspan15 which regulated the ER exit and the 
maturation of ADAM10 [12] we expressed C-terminally myc-tagged Tspan3 or Tspan15 in HeLa 
cells (Fig. 2A(I)) and in the murine neuroblastoma cell line N2A (Fig. 2A,(II)), respectively. As 
described previously, overexpression of Tspan15 led to an increase in the mature form of 
endogenous ADAM10 [12]. In contrast, despite its considerable overexpression, Tspan3 did not 
alter the ratio between the pro- and mature forms of the protease in both cell types (Fig. 2A). An 
interesting observation is that the carboxy-terminal fragments of ADAM10 (ADAM-CTFs of about 
15 kDa), which are proposed to be generated by ADAM9 and ADAM15-mediated shedding 
followed by -secretase cleavage [28] or by autocatalysis [29], were markedly increased upon 
Tspan3 expression in both cell types (Fig. 2A). Tspan3 overexpression in murine neuroblastoma 
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N2A cells mainly increased the possible intracellular domain 15 kDa CTF of ADAM10 which is 
most likely a product of -secretase processing (Fig. 2A,(II)).  
To analyse a possible change in the surface expression of ADAM10, we analyzed N2A cells using 
surface biotinylation (Fig. 2B(I)) and fluorescence activated cell sorting (Fig. 2B(II)). Tspan15 led 
to a considerable increase in the surface levels of ADAM10 but Tspan3 did not affect the amount of 
ADAM10 at the surface (Fig. 2B). Taken together, our data suggests that Tspan3 modulates the 
ectodomain shedding and intramembrane proteolysis of ADAM10 without affecting the maturation 
of the protease and its delivery to the cell surface.  
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Figure 2: Tspan3 expression accelerates ADAM10 CTF generation without increasing 
ADAM10 surface levels. (A) Murine Tspan3-myc (Tsp3) and Tspan15-myc (Tsp15) expressed in 
HeLa cells (I). After immunoblotting ADAM10 was detected using an ADAM10-specific C-
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
   19 
 
terminal antibody and Tspan3-myc or Tspan15-myc were detected using an anti-myc antibody. 
Carboxy-terminal fragments (CTFs) of ADAM10 are increased 3.5 fold after Tspan3 expression. 
No change in the mature (m) form of ADAM10 was observed after Tspan3 but after Tspan15 
expression. (II) Murine Tspan3-myc and Tspan15-myc expressed in murine N2A neuroblastoma 
cells. The 15 kDa ADAM10 CTF is predominantly increased after Tspan3 expression. Tspan15 
shifted the ADAM10 proform (p) to the mature form (m); Tspan3 did not show such an effect. (B) 
Surface biotinylation and (C) fluorescence activated cell sorting (FACS) analysis confirmed a 
higher level of surface ADAM10 in N2A cells after expression of Tspan15 but not after Tspan3 
expression. N2A cells were biotinylated after transfection with either an empty vector (mock), 
murine Tspan3-myc or Tspan15-myc. Following cell lysis total protein samples were taken and 
biotin-labeled proteins precipitated (pulldown). After immunoblotting Tspan3-myc, Tspan15-myc, 
ADAM10 and GAPDH as a negative control were detected. Abbreviations: Ab: antibody control; 
UT: untransfected. A one-way ANOVA statistical analysis followed by Bonferroni’s multiple 
comparisons test was performed (*, p˂0,05, **, p˂0,01***, p˂0,001). 
 
Tspan3 expression affects ADAM10-mediated APP carboxy-terminal C83 fragment generation 
Although Tspan3 overexpression did not overtly affect the cellular localization of ADAM10, we 
also determined what effect it would have on ADAM10 activity. To do this we analyzed its impact 
on ADAM10-dependent generation of membrane-bound APP carboxy-terminal fragment (APP-
CTF) as well as the generation of the CTF of the ADAM10 substrate, N-cadherin. Whereas Tspan3 
expression led to a 2.9 fold increase in APP-CTF, it had no apparent effect on the generation of the 
N-cadherin-CTF (Fig. 3A, Suppl. Fig. S4). In contrast, Tspan15 overexpression increased N-
cadherin cleavage (CTF-generation) while only mildly affecting the generation of APP-CTFs 
(Fig. 3A, Suppl. Fig. S4). Inhibition of ADAM10 after Tspan3 overexpression using a well 
described hydroxamate-based drug (GI254023X) [30] also reduced the level of the APP-CTFs to 
almost mock transfected levels confirming that the Tspan3 effect was to a large part mediated by 
ADAM10 (Fig. 3B). Downregulation of the protease by ADAM10-specific siRNA in N2A cells led 
to a similar effect (i.e. a reduction of the Tspan-3-dependent appearance of APP-CTFs) (Fig. 3C). 
Also, in human embryonic kidney 293 (HEK) cells CRISPR/Cas9-mediated deletion of ADAM10 
but not ADAM17 slightly reduced the appearance of the APP-CTF after Tspan3 expression 
(Fig. 3D).  
In agreement with the identified role of ADAM10 as the major APP -secretase [8,9,31] in HEK 
cells overexpressing the Swedish mutant of APP, overexpression of Tspan3 preferentially increased 
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levels of the C83 APP fragment (-CTF, Fig. 3E). Likewise, in murine N2A cells a gel system 
allowing a separation of the APP-derived CTFs revealed that Tspan3 mainly affected the production 
of the endogenous murine C83 species and not the C99 fragments of APP-CTFs and inhibition of - 
and -secretase did not alter the amount of this fragment (Suppl. Fig. S5).  
Moreover, using HEK cells that stably expressed the Swedish mutant form of APP 
(K595N/M596L), we observed that Tspan3 significantly reduced the level of amyloid-protein 
(A) in the supernatant of these cells but only mildly altered the level of the soluble sAPP 
ectodomain (Fig. 3F) suggesting that in the mutant APP-swe expressing cells the generation of 
intracellular -CTF and extracellular sAPP follow different kinetics, or that their stability is 
differentially regulated by Tspan3. Alternatively, the -CTF may be generated by ADAM10-
mediated trimming of the -CTF. 
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Figure 3: Tspan3 expression leads to an ADAM10-mediated increase of the APP -CTF 
(C83). (A) Tspan3-myc (Tsp3) expression in HeLa cells increases the levels of the APP-CTFs but 
does not affect the N-Cadherin CTF production. Expressing Tspan15-myc (Tsp15) only moderately 
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affects APP-CTF generation yet clearly increases the formation of the N-Cadherin CTF. (B) 
Addition of a hydroxamate-based inhibitor of ADAM10 (GI254023X) reduced the Tspan3-induced 
generation of the APP-CTF in HeLa cells. Actin loading and the transfected Tspan3 are shown in 
the lower panels. A quantification of the APP-CTF generation in the presence and absence of the 
inhibitor is shown. (C) siRNA-mediated downregulation of ADAM10 in N2A cells also reduced the 
generation of APP-CTFs after Tspan3 expression. Scrambled control siRNA was used as a control. 
A quantification of total ADAM10 and APP-CTF levels is shown next to the blot. (D) HEK cells 
with CRISPR/Cas9-mediated-knockout of ADAM10 or ADAM17 were used to transfect Tspan3-
myc or a vector control (mock). APP-CTF expression was slightly reduced in ADAM10-deficient 
cells. The expression of ADAM10 and ADAM17 is controlled by immunoblots. A quantification of 
APP-CTF levels relative to the wild-type mock control is shown below the blot (n=4 experiments).  
(E) Stably transfected HEK cells expressing the Swedish (swe) mutation of APP were transfected 
with Tspan3-myc and immunoblot analysis revealed an accumulation of the APP-C83 CTF. In the 
same cells immunoblot analysis showed that Tspan3 expression reduced the level of A but did not 
affect the generation of sAPP. Quantification is shown below the blot. Statistical significance was 
determined using Student’s and ANOVA-test (*, p˂0,05, **, p˂0,01***, p˂0,001). 
 
Tspan3 is mainly localized in endocytic vesicles and interacts with the amyloid precursor protein 
and presenilin-1 
To better understand the effect of Tspan3 on APP processing and CTF generation we first analyzed 
the subcellular localization of Tspan3 in HeLa cells. Myc-tagged Tspan3 showed a prominent co-
localization with the early endosome protein EEA1 as well as the lysosomal membrane protein 
LIMP-2 (Fig. 4A(I,II)) with minor amounts at the plasma membrane. No apparent co-localization 
was observed with the protein disulfide-isomerase (PDI) as an endoplasmic reticulum (ER) marker 
(Fig. 4A(III)). Also at the endogenous level, Tspan3 co-localized in part with Rab5 and LAMP-2 
(Fig. 4A(IV,V)) suggesting that the steady state distribution of Tspan3 is mainly in endosomes and 
lysosomes, respectively. Both endogenous but also overexpressed APP showed a prominent co-
localization with myc-tagged Tspan3 in HeLa cells (Fig. 4B) suggesting that APP is part of a 
Tspan3 containing protein complex. Co-immunoprecipitation experiments in human APP-
expressing HEK cells confirmed that both full length APP (fl-APP) and also APP-CTFs could be 
pulled down by precipitation of Tspan3 (Fig. 4C). Interestingly, we also found the N-terminal 
fragment of presenilin-1 in the Tspan3 precipitate suggesting that Tspan3 provides an interaction 
platform for - and -secretases as well as for their common substrate APP (Fig. 4D). Expression of 
Tspan3 but not Tspan15 in N2A cells caused a trend towards an increase in surface expression of 
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full length APP and a significant increase in surface APP-CTF (Fig. 4E, Suppl. Fig. S6) as well as 
the presenilin-1-CTF (Suppl. Fig. S6) as revealed in a surface biotinylation experiment arguing for 
an APP and presenilin stabilizing role of Tspan3 at both the plasma membrane and possibly also 
within the endocytic pathway.  
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Figure 4: Tspan3 localizes to the endocytic pathway and interacts with APP and presenilin-1 
(A) I, II, III: Murine Tspan3-myc expressed in HeLa cells. IV, V: Endogenous Tspan3 in HeLa 
cells. Confocal immunofluorescence pictures were taken using an anti-PDI antibody (III), an anti-
LIMP-2 antibody (II), an anti-EEA1 antibody, an anti-Rab5 antibody (IV) and an anti -LAMP-2 
antibody (V). (B) I, II Co-localization of endogenous APP (I) or transfected APP695 (II) with 
Tspan3-myc in HeLa cells. Scale bars for A and B represent 10 µm. (C) Expression constructs of 
murine Tspan3-myc and murine ADAM10 were transiently co-expressed in HeLa cells. Tspan3-
myc (35-37 kDa) was immunoprecipitated (IP) using an anti-myc antibody and co-precipitation 
(coIP) of APP and presenilin-1 was detected with an anti-APP and anti-presenilin antibody. 
Abbreviations: murine ADAM10 (A10), murine Tspan3-myc (Tspan3), amyloid precursor protein 
(APP), fl: full length protein; CTF: carboxy-terminal fragments; NTF: amino terminal fragments. 
(D) Hypothetical model of the Tspan3 complex comprised of ADAM10, APP, APP-CTF and the -
secretase complex. (E) N2A cells were biotinylated after transfection with either the mock vector or 
murine Tspan3-myc or Tspan15-myc. Following cell lysis total protein samples were taken and 
after precipitation of biotin-labeled proteins immunoblotting of total lysates and bound fractions 
was performed. Tspan3-myc, and APP full length (fl) and APP carboxy-terminal fragments (APP-
CTF) were detected. Quantification of the experiment (n=6) is provided below the blot. Statistical 
significance was determined using ANOVA ( **, p˂0,01). 
 
 
Mutation of a Tspan3 endocytosis motif causes decreased turnover of APP-CTFs 
The increased levels of APP caused by the overexpression of Tspan3 prompted the question of 
whether modulating surface levels of Tspan3 would alter the expression of full length APP and 
APP-CTFs. We identified a “YELL” motif within the C-terminal cytoplasmic domain of Tspan3 
(Fig. 5A) which fits well with the common YXXΦ endocytosis motif, where Φ is a bulky 
hydrophobic amino acid [32]. Mutating the Tspan3 tyrosine residue 243 to alanine (Tspan3Y243A) 
resulted in a more prominent surface expression of Tspan3 and reduced co-localization with the 
early endosomal marker EEA1 in transfected HeLa cells (Fig. 5B). Surface biotinylation in APP-
expressing N2A cells confirmed the increased surface levels of the Tspan3Y243A mutant (Fig. 5C) 
which was accompanied by an increased surface expression of full length endogenous APP and 
APP-CTF (Fig. 5D).  
Our experiments point to a role of Tspan3 as an interaction scaffold for ADAM10. siRNA-mediated 
downregulation of endogenous Tspan3 in human neuroblastoma SH-SY5Y cells did not obviously 
affect the expression levels of APP, APP-CTFs and ADAM10 (Fig. 5E(I)). To evaluate if the 
absence of Tspan3 is compensated by other tetraspanins, the transcription level of TspanC6 
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tetraspanins (Tspan6, Tspan7, Tspan12 and CD63) and Tspan5 was analyzed (Fig. 5E(II) but no 
significant changes were observed. Tspan7 transcription was not detected in this cell-line.   
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Figure 5: Mutation of a Tspan3 cytoplasmic endocytosis motif affects Tspan3 and APP 
surface expression. (A) Scheme of Tspan3 in complex with ADAM10 and APP. In the magnified 
view the “YELL” endocytosis motif within its carboxy-terminal cytoplasmic domain of Tspan3 is 
depicted. (B) Localization of the wild type (wt) Tspan3-myc and the Tspan3Y243A-myc mutant in 
transfected HeLa cells as revealed by fluorescence confocal microscopy. Scale bars: 10 m. Co-
localization of Tspan3 with EEA1 was quantified by determining the Pearsons’correlation 
coefficient. (C) HeLa cells were biotinylated after transfection with either the wt Tspan3-myc or the 
mutant Tspan3Y243A-myc. Following cell lysis total protein samples were taken and after biotin-
labeled proteins were precipitated immunoblotting of total lysates and bound fractions was 
performed. Tspan3-myc was detected. (D) Surface biotinylation of N2A APP cells transfected with 
wt Tspan3-myc (Tsp3), mutant Tspan3Y243A-myc (Tsp3Y243A) or Tspan15-myc. Cells were lysed, 
total protein lysates taken and biotin-labeled proteins precipitated. Total lysates and precipitates 
were subjected to immunoblot. Tspan3, Tspan3Y243A and Tspan15, ADAM10, full length (fl)APP 
and carboxy-terminal fragments (CTFs) were detected and quantified (shown below the blots) (E) 
(I) siRNA-mediated knockdown of Tspan3 in human neuroblastoma SH-SY5Y cells. A 
quantification of the ratio of mature and proform of ADAM10 as well as APP-CTFs is provided 
next to the blot. (II) qPCR analysis of Tspan3, 5, 6, 7, 12 and CD63 gene transcription in Tspan3 
(Tsp3) siRNA or control (ctrl) siRNA treated SH-SY5Y cells. The histogram shows the the 
calculated mean value ± SD. Statistical significance was tested using Student’s t-test (** p˂0,01). 
 
Tspan3-deficiency is most likely compensated in vivo 
To address the in vivo role of Tspan3 we have generated Transcription activator-like effector 
nuclease (TALEN)-mediated Tspan3 knockout mice. The resulting mice contain an insertion of 26 
nucleotides with a new XbaI restriction site in exon 2 of the Tspan3 locus leading to a premature 
stop codon (Fig. 6A). The deficiency of Tspan3 expression was validated by immunoblot analysis 
of different tissues (Suppl. Fig. S7) including brain (Fig. 6B). Tspan3-deficient mice did not reveal 
an overt phenotype and obvious morphological alterations in the brain by the age of six months. 
Interestingly, similar to the siRNA experiment in cultured cells (Fig. 5E), the level of ADAM10, 
PrP
c
, fl-APP and APP-CTFs were not obviously affected by the lack of Tspan3 (Fig. 6B) suggesting 
that compensatory mechanisms (e.g. other tetraspanins) exist in vivo which can replace Tspan3 and 
contribute to the stabilization of APP and APP-cleavage products. Analyzing the expression level of 
selected tetraspanins by qRT-PCR in brains from wild type and Tspan3-deficient littermates indeed 
revealed about a five-fold increase in the expression of Tspan7 (belonging to the TspanC6 family) 
but also an approximate 30-fold increase of Tspan5 (as a member of the TspanC8 family) (Fig. 6C). 
Other tetraspanins were only slightly (Cd63, Tspan12) or clearly (Tspan6) downregulated. The 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
   28 
 
possible compensatory role of Tspan7 was validated by heterologous expression in N2A cells. 
Similar to Tspan3 also Tspan7 led to a significant increase in the generation of APP-CTFs (Fig. 
6D). 
Our in vivo data indicate that the lack of Tspan3 causes a complex adaptation of the expression of 
other tetraspanin family members which may contribute to an apparent normal function of 
ADAM10 and processing of its substrates despite a depletion of Tspan3.  
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Figure 6: Knockout of Tspan3 in mice is likely compensated by other tetraspanins. 
(A) Scheme of the used targeting strategy for the generation of Tspan3 knockout mice. Tspan3 exon 
2-specific TALEN oligonucleotides were used to induce a double-strand break. Following, an 
additional 46 bp single stranded Oligodeoxynulceotid (ssODN) was partially incorporated by 
homology-directed repair, resulting in a frameshift mutation and a premature stop codon. (B) 
Analysis of brain tissue from wild type (wt, n=6) and Tspan3 knockout (ko, n=7) mice. Brain 
lysates were immunoblotted and the expression of ADAM10, Tspan3, the cellular prion protein 
PrP
c
, GAPDH, APP and beta-tubulin was analyzed. (C) qPCR Analysis of Adam10, Tspan6, 
Tspan7, Cd63, Tspan12 and Tspan5 gene transcription in brain tissues isolated from wild type (wt) 
or Tspan3 knockout (Tsp3 ko) mice. The data is represented as histogram showing the mean value 
± SD of the calculated, relative mRNA level. Statistical significance was determined using 
Student’s t-test (** p˂0,01, *** p˂0,001). (D) Murine myc-tagged Tspan3 (Tsp3) or Tspan7 (Tsp7) 
were expressed in N2A cells. Transfection of an empty vector served as a mock control. Full length 
(fl) APP and APP-CTFs were analyzed by immunoblot using a C-terminal APP antibody. 
Quantification is shown beside the blots. Statistical analysis was performed with one-way ANOVA 
followed by Bonferroni’s multiple comparisons test (** p˂0,01). 
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Discussion 
The functional analysis of tetraspanins has been partially hampered by their redundant functions 
and their ability to form membrane-embedded protein domains which are able to interact with a 
number of membrane proteins. Such tetraspanin enriched microdomains [5] organize a spatial 
arrangement of membrane proteins thereby affecting biological processes like cell adhesion, 
signaling, endocytosis and proteolysis [5,1,33,34]. The pathogenic relevance of APP proteolysis by 
the - and -secretases is also affected by tetraspanins [35,36,11,14,12,37]. A recent study revealed 
that tetraspanins may physically associate with the - and -secretase complex in an active 
multiprotease complex at the plasma-membrane [17]. In agreement with this study we observed that 
Tspan3 interacts with both ADAM10 and presenilins. Importantly, it also assists to group APP as a 
substrate and the C-terminal cleavage product of APP in this complex. Our cell-based experiments 
reveal that Tspan3 is mainly found within the endocytic compartment and its endocytosis affects the 
cell surface expression and stability of its protein partners. We found Tspan3 to act in a different 
manner as the hitherto described tetraspanins belonging to the Tspan C8 family [35,36,11,14,12,16] 
by not having an obvious impact on the maturation and intracellular transport of ADAM10 from the 
endoplasmic reticulum to the plasma membrane. Tspan3, a tetraspanin member with a pronounced 
expression in murine and human brain and in migratory neural crest cells [21] seems to excert 
stabilizing functions on ADAM10 and certain associated substrates (including APP and PrP
c
) once 
they have reached the plasma membrane and become endocytosed. In this regard, it is of note that 
presenilins are partially found in late endosomes/lysosomes and they are involved in intracellular 
A production [38]. It is attractive to speculate that Tspan3 and other intracellular Tspans modulate 
the activity of intracellular amyloidogenesis. In how far Tspan3 also participates in the cell surface 
control and endocytosis of other cell surface molecules like claudin-11 and beta 1 integrin in 
oligodendrocytes or with the Nogo-A receptor S1PR2 in a similar manner [18-20] has not yet been 
addressed. Mechanisms of how exactly endocytosis of Tspan3 together with its bindings partners 
are controlled, remain to be determined. In case of the tetraspanin CD63, an association with 
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adaptor protein complexes 2 and 3 was revealed leading to internalization of the H
+
,K
+
-ATPase 
beta-subunit [39]. Our findings are in agreement with a role of certain tetraspanins in regulating the 
specific tetraspanin-interaction partner network by endocytosis. 
Since Tspan3 was also found in lysosomes of cortical neurons and its overexpression increased 
levels of the APP-C83 fragment (-CTF) it might be speculated that its association with the full 
length form of APP and APP-CTFs after internalization has a protective effect preventing 
premature degradation of the proteins by lysosomal proteases [40]. It is known for some time that 
- and -secretase-derived APP-CTFs are found in late endocytic compartments [41] where A 
generation may also take place [42]. APP endocytosis and its potential control by Tspan3 may also 
affect A production as revealed by experiments where the cytosolic tail of APP was removed 
[43,44]. The observation that Tspan3 expression is increased in AD brains may simply reflect an 
upregulation of the endocytic system in AD [45,46]. However, elevated levels of Tspan3 may also 
directly contribute to C-terminal APP fragments and intracellular A production.  
We could show that Tspan3 also physically interacts with ADAM10 and this binding directly 
affects its proteolysis of APP as revealed by pharmacological inhibition, siRNA-mediated 
knockdown or complete depletion of protease expression. Since overexpression of Tspan3 
preferentially causes an increase in APP-C83 fragments and not of the APP-C99 fragments an 
inhibitory role on the -secretase function seems unlikely. By increasing and stabilizing the APP -
CTF, Tspan3 could also promote -secretase cleavage of APP. The biological effects we observed 
in our cell-based assays may reflect a mixture of effects related to a stabilization of the protein 
complexes and the embedded secretase substrates within the endocytic pathway and a possible 
selective effect of Tspan3 on ADAM10-mediated proteolysis of APP but not N-cadherin, another 
well-known ADAM10 substrate [47]. This substrate specificity may be explained by specific 
interactions within the tetraspanin-enriched domains that allow more direct contact between the 
Tspan3/ADAM10 complex and APP as compared to N-cadherin. 
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Surprisingly, deficiency of Tspan3 in human neuroblastoma cells and in Tspan3 knockout mice 
neither directly affect the stability of ADAM10 nor the stability and proteolytic processing of APP. 
A compensation by other members of the tetraspanin family seems likely and is supported by our 
observation that Tspan5 and Tspan7 are dramatically upregulated in the brains of the Tspan3 
knockout mice. A lack of an upregulation in the neuroblastoma cell line SH-SY5Y suggest that the 
regulation of Tspan expression is cell-type specific. Tspan7 belongs to the TspanC6 subfamily and 
it is likely that similar to Tspan5,10,14,15,17 and 33 [11-14] its increased expression could 
accelerate the plasma membrane delivery of ADAM10. A functional effect may therefore be 
masked by the redundant role and an efficient replacement of certain tetraspanins by others in order 
to ensure an efficient protein network. The lack of an overt phenotype in the Tspan3 knockout mice 
but also many other Tspan-deficient mice [33] supports such a view. Future Tspan knockout studies 
are required to better understand the ADAM10/Tspan interaction networks and their impact on the 
proteolysis of APP and other substrates. Such studies are also required to define Tspans as novel 
drug targets, allowing a more selective modulation of APP secretase activity which usually show a 
broad spectrum of substrates. 
In conclusion, Tspan3 is revealed as a novel interactor of ADAM10 involved in its stabilization and 
that of the -secretase and APP. Due to its predominant localization in endosomes, it may exert 
major roles within the endocytic pathway, modulating the stability of proteolytic products of APP 
and contributing to intracellular A generation. 
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BBA Molecular Cell Research 
Highlights 
 
 Tspan3 was identified as a novel ADAM10 interaction partner  
 Tspan3 modulates ectodomain shedding and intramembrane proteolysis of ADAM10. 
 Tspan3 increases ADAM10-mediated generation of APP -CTFs and reduces Aβ liberation. 
 Tspan3 stabilizes ADAM10, APP and the γ-secretase complex at the plasma membrane  
 Deficiency of Tspan3 is (most likely) compensated by other tetraspanins. 
